The purpose of this study is to identify association between cerebrospinal fluid Alzheimer's Disease's neurodegenerescence biomarkers (tau, ptau, Aß40 and Aß1-42) and occurrence of cognitive deficits in older patients with bipolar disorders.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Enrollment
180
cerebrospinal fluid testing at screening and M36
MRI done at screening and M36
TEP/FDG done at screening and M36
University Hospital, Tours
Tours, France
RECRUITINGFunctionnal/Cognitive evaluation
Global cognitive evaluation : MMSE (Mini-Mental State Examination), CDR, BREF, 5 word of Dubois ADL, IADL.
Time frame: Half an hour
Psychatric evaluation
Semi-directive psychiatric interview.
Time frame: 15 minutes
Psychatric evaluation
Scales for thymus evaluation : GDS, YMRS, BPRS, STAI
Time frame: 15 minutes
Brain MRI
Enable neuropsychological evaluation.
Time frame: 40 minutes
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
done at screening, M12, M24 and M36
ApoE detection done at screening